Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Increased α1-3 fucosylation of α-1-acid glycoprotein (AGP) in pancreatic cancer.

Balmaña M, Giménez E, Puerta A, Llop E, Figueras J, Fort E, Sanz-Nebot V, de Bolós C, Rizzi A, Barrabés S, de Frutos M, Peracaula R.

J Proteomics. 2016 Jan 30;132:144-54. doi: 10.1016/j.jprot.2015.11.006. Epub 2015 Nov 10.

PMID:
26563517
2.

Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines.

Bassagañas S, Allende H, Cobler L, Ortiz MR, Llop E, de Bolós C, Peracaula R.

Cytokine. 2015 Sep;75(1):197-206. doi: 10.1016/j.cyto.2015.04.006. Epub 2015 Apr 28.

PMID:
25934648
3.

Quantitative analysis of N-glycans from human alfa-acid-glycoprotein using stable isotope labeling and zwitterionic hydrophilic interaction capillary liquid chromatography electrospray mass spectrometry as tool for pancreatic disease diagnosis.

Giménez E, Balmaña M, Figueras J, Fort E, de Bolós C, Sanz-Nebot V, Peracaula R, Rizzi A.

Anal Chim Acta. 2015 Mar 25;866:59-68. doi: 10.1016/j.aca.2015.02.008. Epub 2015 Feb 7.

PMID:
25732693
4.

CDX2 can be regulated through the signalling pathways activated by IL-6 in gastric cells.

Cobler L, Pera M, Garrido M, Iglesias M, de Bolós C.

Biochim Biophys Acta. 2014 Sep;1839(9):785-92. doi: 10.1016/j.bbagrm.2014.06.009. Epub 2014 Jun 19.

PMID:
24953186
5.

Activation of the NF-kB pathway downregulates TFF-1 in gastric carcinogenesis.

Cobler L, Mejías-Luque R, Garrido M, Pera M, Badia-Garrido E, de Bolós C.

Virchows Arch. 2013 Oct;463(4):497-507. doi: 10.1007/s00428-013-1469-2. Epub 2013 Aug 14.

PMID:
23942618
6.

α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues.

Pérez-Garay M, Arteta B, Llop E, Cobler L, Pagès L, Ortiz R, Ferri MJ, de Bolós C, Figueras J, de Llorens R, Vidal-Vanaclocha F, Peracaula R.

Int J Biochem Cell Biol. 2013 Aug;45(8):1748-57. doi: 10.1016/j.biocel.2013.05.015. Epub 2013 May 29.

PMID:
23726834
7.

Activation of the BMP4 pathway and early expression of CDX2 characterize non-specialized columnar metaplasia in a human model of Barrett's esophagus.

Castillo D, Puig S, Iglesias M, Seoane A, de Bolós C, Munitiz V, Parrilla P, Comerma L, Poulsom R, Krishnadath KK, Grande L, Pera M.

J Gastrointest Surg. 2012 Feb;16(2):227-37; discussion 237. doi: 10.1007/s11605-011-1758-5. Epub 2011 Nov 11.

PMID:
22076569
8.

Down-regulation of FUT3 and FUT5 by shRNA alters Lewis antigens expression and reduces the adhesion capacities of gastric cancer cells.

Padró M, Cobler L, Garrido M, de Bolós C.

Biochim Biophys Acta. 2011 Dec;1810(12):1141-9. doi: 10.1016/j.bbagen.2011.09.011. Epub 2011 Sep 25.

PMID:
21978830
9.

Regulation of glycosyltransferases and Lewis antigens expression by IL-1β and IL-6 in human gastric cancer cells.

Padró M, Mejías-Luque R, Cobler L, Garrido M, Pérez-Garay M, Puig S, Peracaula R, de Bolós C.

Glycoconj J. 2011 Feb;28(2):99-110. doi: 10.1007/s10719-011-9327-4. Epub 2011 Mar 2.

PMID:
21365246
10.

alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo.

Pérez-Garay M, Arteta B, Pagès L, de Llorens R, de Bolòs C, Vidal-Vanaclocha F, Peracaula R.

PLoS One. 2010 Sep 1;5(9). pii: e12524. doi: 10.1371/journal.pone.0012524.

11.

Purification of erythropoietin from human plasma samples using an immunoaffinity well plate.

Mallorquí J, Llop E, de Bolòs C, Gutiérrez-Gallego R, Segura J, Pascual JA.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Aug 1;878(23):2117-22. doi: 10.1016/j.jchromb.2010.06.025. Epub 2010 Jul 1.

PMID:
20630810
12.

Inflammation modulates the expression of the intestinal mucins MUC2 and MUC4 in gastric tumors.

Mejías-Luque R, Lindén SK, Garrido M, Tye H, Najdovska M, Jenkins BJ, Iglesias M, Ernst M, de Bolós C.

Oncogene. 2010 Mar 25;29(12):1753-62. doi: 10.1038/onc.2009.467. Epub 2010 Jan 11.

PMID:
20062084
13.

Cytotoxicity and enzymatic activity inhibition in cell lines treated with novel iminosugar derivatives.

Padró M, Castillo JA, Gómez L, Joglar J, Clapés P, de Bolós C.

Glycoconj J. 2010 Feb;27(2):277-85. doi: 10.1007/s10719-009-9276-3. Epub 2009 Dec 30.

PMID:
20041292
14.

New screening protocol for recombinant human erythropoietins based on differential elution after immunoaffinity purification.

Mallorquí J, Gutiérrez-Gallego R, Segura J, de Bolòs C, Pascual JA.

J Pharm Biomed Anal. 2010 Jan 5;51(1):255-9. doi: 10.1016/j.jpba.2009.07.019. Epub 2009 Jul 24.

PMID:
19716252
15.

Juvenile polyps have gastric differentiation with MUC5AC expression and downregulation of CDX2 and SMAD4.

Barros R, Mendes N, Howe JR, Reis CA, de Bolos C, Carneiro F, David L, Almeida R.

Histochem Cell Biol. 2009 Jun;131(6):765-72. doi: 10.1007/s00418-009-0579-z. Epub 2009 Mar 6.

PMID:
19266212
16.

Altered gene transcription profiles in fibroblasts harboring either TK2 or DGUOK mutations indicate compensatory mechanisms.

Villarroya J, de Bolós C, Meseguer A, Hirano M, Vilà MR.

Exp Cell Res. 2009 May 1;315(8):1429-38. doi: 10.1016/j.yexcr.2009.02.018. Epub 2009 Mar 3.

PMID:
19265691
17.

Analysis of recombinant human erythropoietin and novel erythropoiesis stimulating protein digests by immunoaffinity capillary electrophoresis-mass spectrometry.

Giménez E, Benavente F, de Bolós C, Nicolás E, Barbosa J, Sanz-Nebot V.

J Chromatogr A. 2009 Mar 20;1216(12):2574-82. doi: 10.1016/j.chroma.2009.01.057. Epub 2009 Jan 23.

PMID:
19217628
18.

IL-6 induces MUC4 expression through gp130/STAT3 pathway in gastric cancer cell lines.

Mejías-Luque R, Peiró S, Vincent A, Van Seuningen I, de Bolós C.

Biochim Biophys Acta. 2008 Oct;1783(10):1728-36. doi: 10.1016/j.bbamcr.2008.05.020. Epub 2008 Jun 4.

19.

Corticosteroid therapy increases membrane-tethered while decreases secreted mucin expression in nasal polyps.

Martínez-Antón A, de Bolós C, Alobid I, Benítez P, Roca-Ferrer J, Picado C, Mullol J.

Allergy. 2008 Oct;63(10):1368-76. doi: 10.1111/j.1398-9995.2008.01678.x. Epub 2008 Jun 5.

PMID:
18547287
20.

Recombinant erythropoietin found in seized blood bags from sportsmen.

Mallorquí J, Segura J, de Bolòs C, Gutiérrez-Gallego R, Pascual JA.

Haematologica. 2008 Feb;93(2):313-4. doi: 10.3324/haematol.12059.

21.

Anti-EPO and anti-NESP antibodies raised against synthetic peptides that reproduce the minimal amino acid sequence differences between EPO and NESP.

Giménez E, de Bolós C, Belalcazar V, Andreu D, Borrás E, De la Torre BG, Barbosa J, Segura J, Pascual JA.

Anal Bioanal Chem. 2007 Aug;388(7):1531-8. Epub 2007 May 30.

PMID:
17534608
22.

Changes in the invasive and metastatic capacities of HT-29/M3 cells induced by the expression of fucosyltransferase 1.

Mejías-Luque R, López-Ferrer A, Garrido M, Fabra A, de Bolós C.

Cancer Sci. 2007 Jul;98(7):1000-5. Epub 2007 Apr 23.

23.

Duodenal-content reflux into the esophagus leads to expression of Cdx2 and Muc2 in areas of squamous epithelium in rats.

Pera M, Pera M, de Bolós C, Brito MJ, Palacín A, Grande L, Cardesa A, Poulsom R.

J Gastrointest Surg. 2007 Jul;11(7):869-74.

PMID:
17440788
24.

Mucin genes (MUC2, MUC4, MUC5AC, and MUC6) detection in normal and pathological endometrial tissues.

Alameda F, Mejías-Luque R, Garrido M, de Bolós C.

Int J Gynecol Pathol. 2007 Jan;26(1):61-5.

PMID:
17197898
25.

Role of sialyltransferases involved in the biosynthesis of Lewis antigens in human pancreatic tumour cells.

Peracaula R, Tabarés G, López-Ferrer A, Brossmer R, de Bolós C, de Llorens R.

Glycoconj J. 2005 Mar;22(3):135-44.

PMID:
16133834
26.

Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands.

Alos L, Lujan B, Castillo M, Nadal A, Carreras M, Caballero M, de Bolos C, Cardesa A.

Am J Surg Pathol. 2005 Jun;29(6):806-13.

PMID:
15897748
27.

Recombinant erythropoietin and analogues: a challenge for doping control.

Pascual JA, Belalcazar V, de Bolos C, Gutiérrez R, Llop E, Segura J.

Ther Drug Monit. 2004 Apr;26(2):175-9. Review.

PMID:
15228161
28.

Diagnostic value of MUC4 immunostaining in distinguishing epithelial mesothelioma and lung adenocarcinoma.

Llinares K, Escande F, Aubert S, Buisine MP, de Bolos C, Batra SK, Gosselin B, Aubert JP, Porchet N, Copin MC.

Mod Pathol. 2004 Feb;17(2):150-7.

29.
30.

Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.

Almeida R, Silva E, Santos-Silva F, Silberg DG, Wang J, De Bolós C, David L.

J Pathol. 2003 Jan;199(1):36-40.

PMID:
12474224
31.

Differences in the O-glycosylation patterns between lung squamous cell carcinoma and adenocarcinoma.

López-Ferrer A, Barranco C, de Bolós C.

Am J Clin Pathol. 2002 Nov;118(5):749-55.

PMID:
12428796
32.

Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution.

Nordman H, Davies JR, Lindell G, de Bolós C, Real F, Carlstedt I.

Biochem J. 2002 May 15;364(Pt 1):191-200.

33.

MUC4 expression is increased in dysplastic cervical disorders.

López-Ferrer A, Alameda F, Barranco C, Garrido M, de Bolós C.

Hum Pathol. 2001 Nov;32(11):1197-202.

PMID:
11727258
34.

Regulation of mucin and glycoconjugate expression: from normal epithelium to gastric tumors.

de Bolos C, Real FX, Lopez-Ferrer A.

Front Biosci. 2001 Oct 1;6:D1256-63. Review.

PMID:
11578953
35.

Apomucin expression and association with Lewis antigens during gastric development.

López-Ferrer A, Barranco C, de Bolós C.

Appl Immunohistochem Mol Morphol. 2001 Mar;9(1):42-8.

PMID:
11277414
36.

Mucins as differentiation markers in bronchial epithelium. Squamous cell carcinoma and adenocarcinoma display similar expression patterns.

López-Ferrer A, Curull V, Barranco C, Garrido M, Lloreta J, Real FX, de Bolós C.

Am J Respir Cell Mol Biol. 2001 Jan;24(1):22-29.

PMID:
11152646
37.

Polymorphism of human mucin genes in chest disease: possible significance of MUC2.

Vinall LE, Fowler JC, Jones AL, Kirkbride HJ, de Bolós C, Laine A, Porchet N, Gum JR, Kim YS, Moss FM, Mitchell DM, Swallow DM.

Am J Respir Cell Mol Biol. 2000 Nov;23(5):678-86.

PMID:
11062147
38.

Role of fucosyltransferases in the association between apomucin and Lewis antigen expression in normal and malignant gastric epithelium.

López-Ferrer A, de Bolós C, Barranco C, Garrido M, Isern J, Carlstedt I, Reis CA, Torrado J, Real FX.

Gut. 2000 Sep;47(3):349-56.

39.

Polyclonal and monoclonal techniques.

Real FX, de Bolós C, Oosterwijk E.

Methods Mol Biol. 2000;125:353-68. Review. No abstract available.

PMID:
10820773
40.

Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas.

Reis CA, David L, Carvalho F, Mandel U, de Bolós C, Mirgorodskaya E, Clausen H, Sobrinho-Simões M.

J Histochem Cytochem. 2000 Mar;48(3):377-88.

PMID:
10681391
41.

Mucins and mucin-associated carbohydrate antigens expression in gastric carcinoma cell lines.

Carvalho F, David L, Aubert JP, López-Ferrer A, De Bolós C, Reis CA, Gärtner F, Peixoto A, Alves P, Sobrinho-Simões M.

Virchows Arch. 1999 Nov;435(5):479-85.

PMID:
10592051
42.

Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression.

Reis CA, David L, Correa P, Carneiro F, de Bolós C, Garcia E, Mandel U, Clausen H, Sobrinho-Simões M.

Cancer Res. 1999 Mar 1;59(5):1003-7.

43.

Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion.

Hennebicq-Reig S, Lesuffleur T, Capon C, De Bolos C, Kim I, Moreau O, Richet C, Hémon B, Recchi MA, Maës E, Aubert JP, Real FX, Zweibaum A, Delannoy P, Degand P, Huet G.

Biochem J. 1998 Aug 15;334 ( Pt 1):283-95.

44.

MUC6 expression in breast tissues and cultured cells: abnormal expression in tumors and regulation by steroid hormones.

de Bolòs C, Gumà M, Barranco C, Garrido M, Kim YS, Real FX.

Int J Cancer. 1998 Jul 17;77(2):193-9.

45.

GalNAc-alpha-O-benzyl inhibits NeuAcalpha2-3 glycosylation and blocks the intracellular transport of apical glycoproteins and mucus in differentiated HT-29 cells.

Huet G, Hennebicq-Reig S, de Bolos C, Ulloa F, Lesuffleur T, Barbat A, Carrière V, Kim I, Real FX, Delannoy P, Zweibaum A.

J Cell Biol. 1998 Jun 15;141(6):1311-22.

46.

Biosynthesis of mucins (MUC2-6) along the longitudinal axis of the human gastrointestinal tract.

Van Klinken BJ, Dekker J, Büller HA, de Bolòs C, Einerhand AW.

Am J Physiol. 1997 Aug;273(2 Pt 1):G296-302.

PMID:
9277407
48.

Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation.

Delannoy P, Kim I, Emery N, De Bolos C, Verbert A, Degand P, Huet G.

Glycoconj J. 1996 Oct;13(5):717-26.

PMID:
8909998
49.
50.

Characterization of mucins and proteoglycans synthesized by a mucin-secreting HT-29 cell subpopulation.

Huet G, Kim I, de Bolos C, Lo-Guidice JM, Moreau O, Hemon B, Richet C, Delannoy P, Real FX, Degand P.

J Cell Sci. 1995 Mar;108 ( Pt 3):1275-85.

Supplemental Content

Loading ...
Support Center